The Function of Autophagy in the Initiation, and Development of Breast Cancer

Ullah, M.F. Breast cancer: current perspectives on the disease status; Breast Cancer Metastasis and Drug Resistance, 2019, pp. 51-64.

Fattahi, M.; Sheervalilou, R.; Hoseinpour, N.; Valiloo, M.; Pedram, N.; Montazeri, V.; Nejati, K.; Abtin, M.; Seif, F.; Alivand, M-R. The correlation between Twist 1 and 2 promoter methylation status and clinicopathologic characteristics of patients with breast cancer. Gene Rep., 2020, 20, 100741.
[http://dx.doi.org/10.1016/j.genrep.2020.100741]

Maghsoodi, M.S.; Khosroshahi, N.S.; Beilankouhi, E.A.V.; Valilo, M.; Feizi, M.A.H. VEGF-634G > C (rs2010963) gene polymorphism and high risk of breast cancer in the Northwest of Iran. Ind. J. Gynecol. Oncol., 2023, 21(1), 6.
[http://dx.doi.org/10.1007/s40944-022-00648-7]

Cocco, S.; Leone, A.; Piezzo, M.; Caputo, R.; Di Lauro, V.; Di Rella, F.; Fusco, G.; Capozzi, M.; Gioia, G.; Budillon, A.; De Laurentiis, M. Targeting autophagy in breast cancer. Int. J. Mol. Sci., 2020, 21(21), 7836.
[http://dx.doi.org/10.3390/ijms21217836] [PMID: 33105796]

Khodabandeh, Z.; Valilo, M.; Velaei, K.; Pirpour Tazehkand, A. The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy. Breast Cancer, 2022, 29(5), 778-789.
[http://dx.doi.org/10.1007/s12282-022-01369-7] [PMID: 35583594]

Mizushima, N. Autophagy: Process and function. Genes Dev., 2007, 21(22), 2861-2873.
[http://dx.doi.org/10.1101/gad.1599207] [PMID: 18006683]

Mizushima, N. The pleiotropic role of autophagy: From protein metabolism to bactericide. Cell Death Differ., 2005, 12(S2)(Suppl. 2), 1535-1541.
[http://dx.doi.org/10.1038/sj.cdd.4401728] [PMID: 16247501]

Yun, C.; Lee, S. The roles of autophagy in cancer. Int. J. Mol. Sci., 2018, 19(11), 3466.
[http://dx.doi.org/10.3390/ijms19113466] [PMID: 30400561]

Dong, C.; Yuan, T.; Wu, Y.; Wang, Y.; Fan, T.W.M.; Miriyala, S.; Lin, Y.; Yao, J.; Shi, J.; Kang, T.; Lorkiewicz, P.; St Clair, D.; Hung, M.C.; Evers, B.M.; Zhou, B.P. Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer. Cancer Cell, 2013, 23(3), 316-331.
[http://dx.doi.org/10.1016/j.ccr.2013.01.022] [PMID: 23453623]

Kim, J.; Kundu, M.; Viollet, B.; Guan, K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat. Cell Biol., 2011, 13(2), 132-141.
[http://dx.doi.org/10.1038/ncb2152] [PMID: 21258367]

Kim, E.; Goraksha-Hicks, P.; Li, L.; Neufeld, T.P.; Guan, K.L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol., 2008, 10(8), 935-945.
[http://dx.doi.org/10.1038/ncb1753] [PMID: 18604198]

Ameisen, J.C. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ., 2002, 9(4), 367-393.
[http://dx.doi.org/10.1038/sj.cdd.4400950] [PMID: 11965491]

Debnath, J. The multifaceted roles of autophagy in tumors-implications for breast cancer. J. Mammary Gland Biol. Neoplasia, 2011, 16(3), 173-187.
[http://dx.doi.org/10.1007/s10911-011-9223-3] [PMID: 21779879]

Maes, H.; Rubio, N.; Garg, A.D.; Agostinis, P. Autophagy: shaping the tumor microenvironment and therapeutic response. Trends Mol. Med., 2013, 19(7), 428-446.
[http://dx.doi.org/10.1016/j.molmed.2013.04.005] [PMID: 23714574]

Espina, V.; Wysolmerski, J.; Edmiston, K.; Liotta, L.A. Attacking breast cancer at the preinvasion stage by targeting autophagy. Womens Health, 2013, 9(2), 157-170.
[http://dx.doi.org/10.2217/WHE.13.5] [PMID: 23477322]

White, E. Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer, 2012, 12(6), 401-410.
[http://dx.doi.org/10.1038/nrc3262] [PMID: 22534666]

Vega-Rubín-de-Celis, S.; Zou, Z.; Fernández, Á.F.; Ci, B.; Kim, M.; Xiao, G.; Xie, Y.; Levine, B. Increased autophagy blocks HER2-mediated breast tumorigenesis. Proc. Natl. Acad. Sci. USA, 2018, 115(16), 4176-4181.
[http://dx.doi.org/10.1073/pnas.1717800115] [PMID: 29610308]

Ahn, J.S.; Ann, E.J.; Kim, M.Y.; Yoon, J.H.; Lee, H.J.; Jo, E.H.; Lee, K.; Lee, J.S.; Park, H.S. Autophagy negatively regulates tumor cell proliferation through phosphorylation dependent degradation of the Notch1 intracellular domain. Oncotarget, 2016, 7(48), 79047-79063.
[http://dx.doi.org/10.18632/oncotarget.12986] [PMID: 27806347]

Niklaus, N.J.; Tokarchuk, I.; Zbinden, M.; Schläfli, A.M.; Maycotte, P.; Tschan, M.P. The multifaceted functions of autophagy in breast cancer development and treatment. Cells, 2021, 10(6), 1447.
[http://dx.doi.org/10.3390/cells10061447] [PMID: 34207792]

Maycotte, P.; Thorburn, A. Targeting autophagy in breast cancer. World J. Clin. Oncol., 2014, 5(3), 224-240.
[http://dx.doi.org/10.5306/wjco.v5.i3.224] [PMID: 25114840]

Maiuri, M.C.; Tasdemir, E.; Criollo, A.; Morselli, E.; Vicencio, J.M.; Carnuccio, R.; Kroemer, G. Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ., 2009, 16(1), 87-93.
[http://dx.doi.org/10.1038/cdd.2008.131] [PMID: 18806760]

Botti, J.; Djavaheri-Mergny, M.; Pilatte, Y.; Codogno, P. Autophagy signaling and the cogwheels of cancer. Autophagy, 2006, 2(2), 67-73.
[http://dx.doi.org/10.4161/auto.2.2.2458] [PMID: 16874041]

Lim, K.H.; Staudt, L.M. Toll-like receptor signaling. Cold Spring Harb. Perspect. Biol., 2013, 5(1), a011247.
[http://dx.doi.org/10.1101/cshperspect.a011247] [PMID: 23284045]

Salminen, A.; Kaarniranta, K.; Kauppinen, A. Beclin 1 interactome controls the crosstalk between apoptosis, autophagy and inflammasome activation: Impact on the aging process. Ageing Res. Rev., 2013, 12(2), 520-534.
[http://dx.doi.org/10.1016/j.arr.2012.11.004] [PMID: 23220384]

Rosenfeldt, M.T.; Ryan, K.M. The multiple roles of autophagy in cancer. Carcinogenesis, 2011, 32(7), 955-963.
[http://dx.doi.org/10.1093/carcin/bgr031] [PMID: 21317301]

Gewirtz, D.A. The four faces of autophagy: Implications for cancer therapy. Cancer Res., 2014, 74(3), 647-651.
[http://dx.doi.org/10.1158/0008-5472.CAN-13-2966] [PMID: 24459182]

Parzych, K.R.; Klionsky, D.J. An overview of autophagy: Morphology, mechanism, and regulation. Antioxid. Redox Signal., 2014, 20(3), 460-473.
[http://dx.doi.org/10.1089/ars.2013.5371] [PMID: 23725295]

Martinet, W.; Agostinis, P.; Vanhoecke, B.; Dewaele, M.; de Meyer, G.R.Y. Autophagy in disease: A double-edged sword with therapeutic potential. Clin. Sci., 2009, 116(9), 697-712.
[http://dx.doi.org/10.1042/CS20080508] [PMID: 19323652]

Cheong, H.; Lu, C.; Lindsten, T.; Thompson, C.B. Therapeutic targets in cancer cell metabolism and autophagy. Nat. Biotechnol., 2012, 30(7), 671-678.
[http://dx.doi.org/10.1038/nbt.2285] [PMID: 22781696]

Berardi, DE; Campodónico, PB; Díaz Bessone, MI; Urtreger, AJ; Todaro, LB Autophagy: Friend or foe in breast cancer development, progression, and treatment. Int. J. Breast Cancer., 2011, 2011, 595092.
[http://dx.doi.org/10.4061/2011/595092]

Notte, A.; Leclere, L.; Michiels, C. Autophagy as a mediator of chemotherapy-induced cell death in cancer. Biochem. Pharmacol., 2011, 82(5), 427-434.
[http://dx.doi.org/10.1016/j.bcp.2011.06.015] [PMID: 21704023]

Shi, W.; Xiao, D.; Wang, L.; Dong, L.; Yan, Z.; Shen, Z. Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy. Cell death & disease, 2012, 3(3), e275-e.

Ravikumar, B.; Sarkar, S.; Davies, J.E.; Futter, M.; Garcia-Arencibia, M.; Green-Thompson, Z.W.; Jimenez-Sanchez, M.; Korolchuk, V.I.; Lichtenberg, M.; Luo, S.; Massey, D.C.O.; Menzies, F.M.; Moreau, K.; Narayanan, U.; Renna, M.; Siddiqi, F.H.; Underwood, B.R.; Winslow, A.R.; Rubinsztein, D.C. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev., 2010, 90(4), 1383-1435.
[http://dx.doi.org/10.1152/physrev.00030.2009] [PMID: 20959619]

Rubinsztein, D.C.; Codogno, P.; Levine, B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov., 2012, 11(9), 709-730.
[http://dx.doi.org/10.1038/nrd3802] [PMID: 22935804]

Klionsky, D.J. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol., 2007, 8(11), 931-937.
[http://dx.doi.org/10.1038/nrm2245] [PMID: 17712358]

Chang, C.Y.; Huang, W.P. Atg19 mediates a dual interaction cargo sorting mechanism in selective autophagy. Mol. Biol. Cell, 2007, 18(3), 919-929.
[http://dx.doi.org/10.1091/mbc.e06-08-0683] [PMID: 17192412]

He, C.; Baba, M.; Klionsky, D.J. Double duty of Atg9 self-association in autophagosome biogenesis. Autophagy, 2009, 5(3), 385-387.
[http://dx.doi.org/10.4161/auto.5.3.7699] [PMID: 19182520]

Autophagosome formation involves cycling of ATG9. Autophagy; Legakis, J.E.; Yen, W-L.; He, C.; Monastyrska, I.; Yorimitsu, T.; Klionsky, D.J., Eds.; Landes Bioscience 810 South Church Street, Georgetown, TX 78626 USA, 2006.

Yen, W.L.; Legakis, J.E.; Nair, U.; Klionsky, D.J. Atg27 is required for autophagy-dependent cycling of Atg9. Mol. Biol. Cell, 2007, 18(2), 581-593.
[http://dx.doi.org/10.1091/mbc.e06-07-0612] [PMID: 17135291]

Klionsky, D.J.; Abeliovich, H.; Agostinis, P.; Agrawal, D.K.; Aliev, G.; Askew, D.S.; Baba, M.; Baehrecke, E.H.; Bahr, B.A.; Ballabio, A.; Bamber, B.A.; Bassham, D.C.; Bergamini, E.; Bi, X.; Biard-Piechaczyk, M.; Blum, J.S.; Bredesen, D.E.; Brodsky, J.L.; Brumell, J.H.; Brunk, U.T.; Bursch, W.; Camougrand, N.; Cebollero, E.; Cecconi, F.; Chen, Y.; Chin, L.S.; Choi, A.; Chu, C.T.; Chung, J.; Clark, R.S.B.; Clarke, P.G.H.; Clarke, S.G.; Clavé, C.; Cleveland, J.L.; Codogno, P.; Colombo, M.I.; Coto-Montes, A.; Cregg, J.M.; Cuervo, A.M.; Debnath, J.; Dennis, P.B.; Dennis, P.A.; Demarchi, F.; Deretic, V.; Devenish, R.J.; Di Sano, F.; Dice, J.F.; Distelhorst, C.W.; Dinesh-Kumar, S.P.; Eissa, N.T.; DiFiglia, M.; Djavaheri-Mergny, M.; Dorsey, F.C.; Dröge, W.; Dron, M.; Dunn, W.A., Jr; Duszenko, M.; Elazar, Z.; Esclatine, A.; Eskelinen, E.L.; Fésüs, L.; Finley, K.D.; Fuentes, J.M.; Fueyo-Margareto, J.; Fujisaki, K.; Galliot, B.; Gao, F.B.; Gewirtz, D.A.; Gibson, S.B.; Gohla, A.; Goldberg, A.L.; Gonzalez, R.; González-Estévez, C.; Gorski, S.M.; Gottlieb, R.A.; Häussinger, D.; He, Y.W.; Heidenreich, K.; Hill, J.A.; Høyer-Hansen, M.; Hu, X.; Huang, W.P.; Iwasaki, A.; Jäättelä, M.; Jackson, W.T.; Jiang, X.; Jin, S.V.; Johansen, T.; Jung, J.U.; Kadowaki, M.; Kang, C.; Kelekar, A.; Kessel, D.H.; Kiel, J.A.K.W.; Kim, H.P.; Kimchi, A.; Kinsella, T.J.; Kiselyov, K.; Kitamoto, K.; Knecht, E.; Komatsu, M.; Kominami, E.; Kondo, S.; Kovács, A.L.; Kroemer, G.; Kuan, C.Y.; Kumar, R.; Kundu, M.; Landry, J.; Laporte, M.; Le, W.; Lei, H.Y.; Levine, B.; Lieberman, A.P.; Lim, K-L.; Lin, F-C.; Liou, W.; Liu, L.F.; Lopez-Berestein, G.; López-Otín, C.; Lu, B.; Macleod, K.F.; Malorni, W.; Martinet, W.; Matsuoka, K.; Mautner, J.; Meijer, A.J.; Meléndez, A.; Michels, P.; Miotto, G.; Mistiaen, W.P.; Mizushima, N.; Mograbi, B.; Moore, M.N.; Moreira, P.I.; Moriyasu, Y.; Motyl, T.; Münz, C.; Murphy, L.O.; Naqvi, N.I.; Neufeld, T.P.; Nishino, I.; Nixon, R.A.; Noda, T.; Nürnberg, B.; Ogawa, M.; Oleinick, N.L.; Olsen, L.J.; Ozpolat, B.; Paglin, S.; Palmer, G.E.; Papassideri, I.S.; Parkes, M.; Perlmutter, D.H.; Perry, G.; Piacentini, M.; Pinkas-Kramarski, R.; Prescott, M.; Proikas-Cezanne, T.; Raben, N.; Rami, A.; Reggiori, F.; Rohrer, B.; Rubinsztein, D.C.; Ryan, K.M.; Sadoshima, J.; Sakagami, H.; Sakai, Y.; Sandri, M.; Sasakawa, C.; Sass, M.; Schneider, C.; Seglen, P.O.; Seleverstov, O.; Settleman, J.; Shacka, J.J.; Shapiro, I.M.; Sibirny, A.A.; Silva-Zacarin, E.C.M.; Simon, H-U.; Simone, C.; Simonsen, A.; Smith, M.A.; Spanel-Borowski, K.; Srinivas, V.; Steeves, M.; Stenmark, H.; Stromhaug, P.E.; Subauste, C.S.; Sugimoto, S.; Sulzer, D.; Suzuki, T.; Swanson, M.S.; Tabas, I.; Takeshita, F.; Talbot, N.J.; Tallóczy, Z.; Tanaka, K.; Tanaka, K.; Tanida, I.; Taylor, G.S.; Taylor, J.P.; Terman, A.; Tettamanti, G.; Thompson, C.B.; Thumm, M.; Tolkovsky, A.M.; Tooze, S.A.; Truant, R.; Tumanovska, L.V.; Uchiyama, Y.; Ueno, T.; Uzcátegui, N.L.; van der Klei, I.J.; Vaquero, E.C.; Vellai, T.; Vogel, M.W.; Wang, H-G.; Webster, P.; Xi, Z.; Xiao, G.; Yahalom, J.; Yang, J-M.; Yap, G.S.; Yin, X-M.; Yoshimori, T.; Yue, Z.; Yuzaki, M.; Zabirnyk, O.; Zheng, X.; Zhu, X.; Deter, R.L.; Zabirnyk, O.; Zheng, X.; Zhu, X.; Deter, R.L. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy, 2008, 4(2), 151-175.
[http://dx.doi.org/10.4161/auto.5338] [PMID: 18188003]

Le Grand, J.N.; Chakrama, F.Z.; Seguin-Py, S.; Fraichard, A.; Delage-Mourroux, R.; Jouvenot, M.; Boyer-Guittaut, M. GABARAPL1 (GEC1): Original or copycat? Autophagy, 2011, 7(10), 1098-1107.
[http://dx.doi.org/10.4161/auto.7.10.15904] [PMID: 21597319]

Behrends, C.; Sowa, M.E.; Gygi, S.P.; Harper, J.W. Network organization of the human autophagy system. Nature, 2010, 466(7302), 68-76.
[http://dx.doi.org/10.1038/nature09204] [PMID: 20562859]

Folkerts, H.; Hilgendorf, S.; Vellenga, E.; Bremer, E.; Wiersma, V.R. The multifaceted role of autophagy in cancer and the microenvironment. Med. Res. Rev., 2019, 39(2), 517-560.
[http://dx.doi.org/10.1002/med.21531] [PMID: 30302772]

Yue, Z.; Jin, S.; Yang, C.; Levine, A.J.; Heintz, N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. USA, 2003, 100(25), 15077-15082.
[http://dx.doi.org/10.1073/pnas.2436255100] [PMID: 14657337]

Eccles, D.M.; Russell, S.E.; Haites, N.E.; Atkinson, R.; Bell, D.W.; Gruber, L.; Hickey, I.; Kelly, K.; Kitchener, H.; Leonard, R. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group Oncogene, 1992, 7(10), 2069-2072.
[PMID: 1408149]

Ajoolabady, A.; Aslkhodapasandhokmabad, H.; Aghanejad, A.; Zhang, Y.; Ren, J. Mitophagy receptors and mediators: therapeutic targets in the management of cardiovascular ageing. Ageing Res. Rev., 2020, 62, 101129.
[http://dx.doi.org/10.1016/j.arr.2020.101129] [PMID: 32711157]

Ajoolabady, A.; Aghanejad, A.; Bi, Y.; Zhang, Y.; Aslkhodapasandhukmabad, H.; Abhari, A.; Ren, J. Enzyme-based autophagy in anti-neoplastic management: From molecular mechanisms to clinical therapeutics. Biochim. Biophys. Acta Rev. Cancer, 2020, 1874(1), 188366.
[http://dx.doi.org/10.1016/j.bbcan.2020.188366] [PMID: 32339608]

Tang, Y; Wang, Y; Wang, C; Yu, M; Li, L; Chen, S Isoliquiritigenin attenuates LPS-induced acute kidney injury through suppression of HMGB1 pathway in renal tubular against ferritinophagy. Preprint, 2020.
[http://dx.doi.org/10.21203/rs.2.24196/v1]

Gatica, D.; Chiong, M.; Lavandero, S.; Klionsky, D.J. Molecular mechanisms of autophagy in the cardiovascular system. Circ. Res., 2015, 116(3), 456-467.
[http://dx.doi.org/10.1161/CIRCRESAHA.114.303788] [PMID: 25634969]

He, C.; Klionsky, D.J. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet., 2009, 43(1), 67-93.
[http://dx.doi.org/10.1146/annurev-genet-102808-114910] [PMID: 19653858]

Rostami, N.; Nikkhoo, A.; Ajjoolabady, A.; Azizi, G.; Hojjat-Farsangi, M.; Ghalamfarsa, G.; Yousefi, B.; Yousefi, M.; Jadidi-Niaragh, F. S1PR1 as a novel promising therapeutic target in cancer therapy. Mol. Diagn. Ther., 2019, 23(4), 467-487.
[http://dx.doi.org/10.1007/s40291-019-00401-5] [PMID: 31115798]

Alizadeh, L.; Zarebkohan, A.; Salehi, R.; Ajjoolabady, A.; Rahmati-Yamchi, M. Chitosan-based nanotherapeutics for ovarian cancer treatment. J. Drug Target., 2019, 27(8), 839-852.
[http://dx.doi.org/10.1080/1061186X.2018.1564923] [PMID: 30596291]

Hashemi, V.; Farhadi, S.; Ghasemi Chaleshtari, M.; Seashore-Ludlow, B.; Masjedi, A.; Hojjat-Farsangi, M.; Namdar, A.; Ajjoolabady, A.; Mohammadi, H.; Ghalamfarsa, G.; Jadidi-Niaragh, F. Nanomedicine for improvement of dendritic cell-based cancer immunotherapy. Int. Immunopharmacol., 2020, 83, 106446.
[http://dx.doi.org/10.1016/j.intimp.2020.106446] [PMID: 32244048]

Ferlay, J.; Ervik, M.; Lam, F.; Colombet, M.; Mery, L.; Piñeros, M. Global cancer observatory: Cancer today. Int. Agency Res. Cancer., 2018, 3(20)

Prat, A.; Perou, C.M. Deconstructing the molecular portraits of breast cancer. Mol. Oncol., 2011, 5(1), 5-23.
[http://dx.doi.org/10.1016/j.molonc.2010.11.003] [PMID: 21147047]

Bigaard, J.; Stahlberg, C.; Jensen, M.B.; Ewertz, M.; Kroman, N. Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007. Breast Cancer Res. Treat., 2012, 136(2), 559-564.
[http://dx.doi.org/10.1007/s10549-012-2269-0] [PMID: 23053655]

Britt, K.L.; Cuzick, J.; Phillips, K.A. Key steps for effective breast cancer prevention. Nat. Rev. Cancer, 2020, 20(8), 417-436.
[http://dx.doi.org/10.1038/s41568-020-0266-x] [PMID: 32528185]

Joshi, H.; Press, M.F. Molecular oncology of breast cancer. In: The Breast; Elsevier, 2018; pp. 282-307.
[http://dx.doi.org/10.1016/B978-0-323-35955-9.00022-2]

Piccart-Gebhart, M.J.; Procter, M.; Leyland-Jones, B.; Goldhirsch, A.; Untch, M.; Smith, I.; Gianni, L.; Baselga, J.; Bell, R.; Jackisch, C.; Cameron, D.; Dowsett, M.; Barrios, C.H.; Steger, G.; Huang, C.-S.; Andersson, M.; Inbar, M.; Lichinitser, M.; Láng, I.; Nitz, U.; Iwata, H.; Thomssen, C.; Lohrisch, C.; Suter, T.M.; Rüschoff, J.; Suto, T.; Greatorex, V.; Ward, C.; Straehle, C.; McFadden, E.; Dolci, M.S.; Gelber, R.D.; Herceptin Adjuvant (HERA) Trial Study Team. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N. Engl. J. Med., 2005, 353(16), 1659-1672.
[http://dx.doi.org/10.1056/NEJMoa052306] [PMID: 16236737]

Denkert, C.; Liedtke, C.; Tutt, A.; von Minckwitz, G. Molecular alterations in triple-negative breast cancer—the road to new treatment strategies. Lancet, 2017, 389(10087), 2430-2442.
[http://dx.doi.org/10.1016/S0140-6736(16)32454-0] [PMID: 27939063]

Hinck, L.; Näthke, I. Changes in cell and tissue organization in cancer of the breast and colon. Curr. Opin. Cell Biol., 2014, 26, 87-95.
[http://dx.doi.org/10.1016/j.ceb.2013.11.003] [PMID: 24529250]

Nielsen, T.O.; Hsu, F.D.; Jensen, K.; Cheang, M.; Karaca, G.; Hu, Z.; Hernandez-Boussard, T.; Livasy, C.; Cowan, D.; Dressler, L.; Akslen, L.A.; Ragaz, J.; Gown, A.M.; Gilks, C.B.; van de Rijn, M.; Perou, C.M. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin. Cancer Res., 2004, 10(16), 5367-5374.
[http://dx.doi.org/10.1158/1078-0432.CCR-04-0220] [PMID: 15328174]

Dass, S.A.; Tan, K.L.; Selva Rajan, R.; Mokhtar, N.F.; Mohd Adzmi, E.R.; Wan Abdul Rahman, W.F.; Tengku Din, T.A.D.A.A.; Balakrishnan, V. Triple negative breast cancer: A review of present and future diagnostic modalities. Medicina, 2021, 57(1), 62.
[http://dx.doi.org/10.3390/medicina57010062] [PMID: 33445543]

Rakha, E.A.; Elsheikh, S.E.; Aleskandarany, M.A.; Habashi, H.O.; Green, A.R.; Powe, D.G.; El-Sayed, M.E.; Benhasouna, A.; Brunet, J.S.; Akslen, L.A.; Evans, A.J.; Blamey, R.; Reis-Filho, J.S.; Foulkes, W.D.; Ellis, I.O. Triple-negative breast cancer: Distinguishing between basal and nonbasal subtypes. Clin. Cancer Res., 2009, 15(7), 2302-2310.
[http://dx.doi.org/10.1158/1078-0432.CCR-08-2132] [PMID: 19318481]

Nounou, MI; ElAmrawy, F; Ahmed, N; Abdelraouf, K; Goda, S; Syed-Sha-Qhattal, H Breast cancer: Conventional diagnosis and treatment modalities and recent patents and technologies. Breast cancer: Basic and clinical research, 2015, 9, S29420.
[http://dx.doi.org/10.4137/BCBCR.S29420]

Herschkowitz, J.I.; Simin, K.; Weigman, V.J.; Mikaelian, I.; Usary, J.; Hu, Z.; Rasmussen, K.E.; Jones, L.P.; Assefnia, S.; Chandrasekharan, S.; Backlund, M.G.; Yin, Y.; Khramtsov, A.I.; Bastein, R.; Quackenbush, J.; Glazer, R.I.; Brown, P.H.; Green, J.E.; Kopelovich, L.; Furth, P.A.; Palazzo, J.P.; Olopade, O.I.; Bernard, P.S.; Churchill, G.A.; Van Dyke, T.; Perou, C.M. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biol., 2007, 8(5), R76.
[http://dx.doi.org/10.1186/gb-2007-8-5-r76] [PMID: 17493263]

Prat, A.; Parker, J.S.; Karginova, O.; Fan, C.; Livasy, C.; Herschkowitz, J.I.; He, X.; Perou, C.M. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res., 2010, 12(5), R68.
[http://dx.doi.org/10.1186/bcr2635] [PMID: 20813035]

Hennessy, B.T.; Gonzalez-Angulo, A.M.; Stemke-Hale, K.; Gilcrease, M.Z.; Krishnamurthy, S.; Lee, J.S.; Fridlyand, J.; Sahin, A.; Agarwal, R.; Joy, C.; Liu, W.; Stivers, D.; Baggerly, K.; Carey, M.; Lluch, A.; Monteagudo, C.; He, X.; Weigman, V.; Fan, C.; Palazzo, J.; Hortobagyi, G.N.; Nolden, L.K.; Wang, N.J.; Valero, V.; Gray, J.W.; Perou, C.M.; Mills, G.B. Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. Cancer Res., 2009, 69(10), 4116-4124.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-3441] [PMID: 19435916]

Creighton, C.J.; Li, X.; Landis, M.; Dixon, J.M.; Neumeister, V.M.; Sjolund, A.; Rimm, D.L.; Wong, H.; Rodriguez, A.; Herschkowitz, J.I.; Fan, C.; Zhang, X.; He, X.; Pavlick, A.; Gutierrez, M.C.; Renshaw, L.; Larionov, A.A.; Faratian, D.; Hilsenbeck, S.G.; Perou, C.M.; Lewis, M.T.; Rosen, J.M.; Chang, J.C. Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. USA, 2009, 106(33), 13820-13825.
[http://dx.doi.org/10.1073/pnas.0905718106] [PMID: 19666588]

Schmadeka, R.; Harmon, B.E.; Singh, M. Triple-negative breast carcinoma: Current and emerging concepts. Am. J. Clin. Pathol., 2014, 141(4), 462-477.
[http://dx.doi.org/10.1309/AJCPQN8GZ8SILKGN] [PMID: 24619745]

Austreid, E.; Lonning, P.E.; Eikesdal, H.P. The emergence of targeted drugs in breast cancer to prevent resistance to endocrine treatment and chemotherapy. Expert Opin. Pharmacother., 2014, 15(5), 681-700.
[http://dx.doi.org/10.1517/14656566.2014.885952] [PMID: 24579888]

DeSantis, C.E.; Ma, J.; Gaudet, M.M.; Newman, L.A.; Miller, K.D.; Goding Sauer, A.; Jemal, A.; Siegel, R.L. Breast cancer statistics, 2019. CA Cancer J. Clin., 2019, 69(6), 438-451.
[http://dx.doi.org/10.3322/caac.21583] [PMID: 31577379]

Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin., 2019, 69(1), 7-34.
[http://dx.doi.org/10.3322/caac.21551] [PMID: 30620402]

White, E. The role for autophagy in cancer. J. Clin. Invest., 2015, 125(1), 42-46.
[http://dx.doi.org/10.1172/JCI73941] [PMID: 25654549]

Mathew, R.; Khor, S.; Hackett, S.R.; Rabinowitz, J.D.; Perlman, D.H.; White, E. Functional role of autophagy-mediated proteome remodeling in cell survival signaling and innate immunity. Mol. Cell, 2014, 55(6), 916-930.
[http://dx.doi.org/10.1016/j.molcel.2014.07.019] [PMID: 25175026]

Karsli-Uzunbas, G.; Guo, J.Y.; Price, S.; Teng, X.; Laddha, S.V.; Khor, S.; Kalaany, N.Y.; Jacks, T.; Chan, C.S.; Rabinowitz, J.D.; White, E. Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov., 2014, 4(8), 914-927.
[http://dx.doi.org/10.1158/2159-8290.CD-14-0363] [PMID: 24875857]

Sun, R.; Shen, S.; Zhang, Y.J.; Xu, C.F.; Cao, Z.T.; Wen, L.P.; Wang, J. Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells. Biomaterials, 2016, 103, 44-55.
[http://dx.doi.org/10.1016/j.biomaterials.2016.06.038] [PMID: 27376558]

Autophagosome formation—the role of ULK1 and Beclin1–PI3KC3 complexes in setting the stage. Seminars in cancer biology; Wirth, M.; Joachim, J.; Tooze, S.A., Eds.; Elsevier, 2013.

Zhang, L.; Fu, L.; Zhang, S.; Zhang, J.; Zhao, Y.; Zheng, Y.; He, G.; Yang, S.; Ouyang, L.; Liu, B. Discovery of a small molecule targeting ULK1-modulated cell death of triple negative breast cancer in vitro and in vivo. Chem. Sci., 2017, 8(4), 2687-2701.
[http://dx.doi.org/10.1039/C6SC05368H] [PMID: 28553505]

Jain, M.V.; Paczulla, A.M.; Klonisch, T.; Dimgba, F.N.; Rao, S.B.; Roberg, K.; Schweizer, F.; Lengerke, C.; Davoodpour, P.; Palicharla, V.R.; Maddika, S.; Łos, M. Interconnections between apoptotic, autophagic and necrotic pathways: Implications for cancer therapy development. J. Cell. Mol. Med., 2013, 17(1), 12-29.
[http://dx.doi.org/10.1111/jcmm.12001] [PMID: 23301705]

Zarzynska, JM The importance of autophagy regulation in breast cancer development and treatment. BioMed Res. Int., 2014, 2014
[http://dx.doi.org/10.1155/2014/710345]

Gentile, M.; Ahnström, M.; Schön, F.; Wingren, S. Candidate tumour suppressor genes at 11q23–q24 in breast cancer: Evidence of alterations in PIG8, a gene involved in p53-induced apoptosis. Oncogene, 2001, 20(53), 7753-7760.
[http://dx.doi.org/10.1038/sj.onc.1204993] [PMID: 11753653]

Tian, Y.; Li, Z.; Hu, W.; Ren, H.; Tian, E.; Zhao, Y.; Lu, Q.; Huang, X.; Yang, P.; Li, X.; Wang, X.; Kovács, A.L.; Yu, L.; Zhang, H. C. elegans screen identifies autophagy genes specific to multicellular organisms. Cell, 2010, 141(6), 1042-1055.
[http://dx.doi.org/10.1016/j.cell.2010.04.034] [PMID: 20550938]

Kocaturk, N.M.; Akkoc, Y.; Kig, C.; Bayraktar, O.; Gozuacik, D.; Kutlu, O. Autophagy as a molecular target for cancer treatment. Eur. J. Pharm. Sci., 2019, 134, 116-137.
[http://dx.doi.org/10.1016/j.ejps.2019.04.011] [PMID: 30981885]

Bao, J.; Shi, Y.; Tao, M.; Liu, N.; Zhuang, S.; Yuan, W. Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy. Clin. Sci., 2018, 132(21), 2299-2322.
[http://dx.doi.org/10.1042/CS20180563] [PMID: 30293967]

Del Bel, M.; Abela, A.R.; Ng, J.D.; Guerrero, C.A. Enantioselective chemical syntheses of the furanosteroids (−)-viridin and (−)-viridiol. J. Am. Chem. Soc., 2017, 139(20), 6819-6822.
[http://dx.doi.org/10.1021/jacs.7b02829] [PMID: 28463562]

Mauvezin, C.; Neufeld, T.P. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy, 2015, 11(8), 1437-1438.
[http://dx.doi.org/10.1080/15548627.2015.1066957] [PMID: 26156798]

Jiang, P.D.; Zhao, Y.L.; Deng, X.Q.; Mao, Y.Q.; Shi, W.; Tang, Q.Q.; Li, Z.G.; Zheng, Y.Z.; Yang, S.Y.; Wei, Y.Q. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer. Biomed. Pharmacother., 2010, 64(9), 609-614.
[http://dx.doi.org/10.1016/j.biopha.2010.06.004] [PMID: 20888174]

Rodenhiser, D.I.; Andrews, J.D.; Vandenberg, T.A.; Chambers, A.F. Gene signatures of breast cancer progression and metastasis. Breast Cancer Res., 2011, 13(1), 201.
[http://dx.doi.org/10.1186/bcr2791] [PMID: 21345283]

Won, K.Y.; Kim, G.Y.; Kim, Y.W.; Song, J.Y.; Lim, S.J. Clinicopathologic correlation of beclin-1 and bcl-2 expression in human breast cancer. Hum. Pathol., 2010, 41(1), 107-112.
[http://dx.doi.org/10.1016/j.humpath.2009.07.006] [PMID: 19762066]

Mauthe, M.; Langereis, M.; Jung, J.; Zhou, X.; Jones, A.; Omta, W.; Tooze, S.A.; Stork, B.; Paludan, S.R.; Ahola, T.; Egan, D.; Behrends, C.; Mokry, M.; de Haan, C.; van Kuppeveld, F.; Reggiori, F. An siRNA screen for ATG protein depletion reveals the extent of the unconventional functions of the autophagy proteome in virus replication. J. Cell Biol., 2016, 214(5), 619-635.
[http://dx.doi.org/10.1083/jcb.201602046] [PMID: 27573464]

Florey, O.; Gammoh, N.; Kim, S.E.; Jiang, X.; Overholtzer, M. V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation. Autophagy, 2015, 11(1), 88-99.
[http://dx.doi.org/10.4161/15548627.2014.984277] [PMID: 25484071]

Yang, W.; Jiang, C.; Xia, W.; Ju, H.; Jin, S.; Liu, S.; Zhang, L.; Ren, G.; Ma, H.; Ruan, M.; Hu, J. Blocking autophagy flux promotes interferon-alpha-mediated apoptosis in head and neck squamous cell carcinoma. Cancer Lett., 2019, 451, 34-47.
[http://dx.doi.org/10.1016/j.canlet.2019.02.052] [PMID: 30862487]

Kadkhoda, J.; Tarighatnia, A.; Tohidkia, M.R.; Nader, N.D.; Aghanejad, A. Photothermal therapy-mediated autophagy in breast cancer treatment: Progress and trends. Life Sci., 2022, 298, 120499.
[http://dx.doi.org/10.1016/j.lfs.2022.120499] [PMID: 35346674]

Tooze, S.A.; Yoshimori, T. The origin of the autophagosomal membrane. Nat. Cell Biol., 2010, 12(9), 831-835.
[http://dx.doi.org/10.1038/ncb0910-831] [PMID: 20811355]

Cui, Q.; Tashiro, S.; Onodera, S.; Minami, M.; Ikejima, T. Autophagy preceded apoptosis in oridonin-treated human breast cancer MCF-7 cells. Biol. Pharm. Bull., 2007, 30(5), 859-864.
[http://dx.doi.org/10.1248/bpb.30.859] [PMID: 17473426]

Tanida, I.; Ueno, T.; Kominami, E. LC3 conjugation system in mammalian autophagy. Int. J. Biochem. Cell Biol., 2004, 36(12), 2503-2518.
[http://dx.doi.org/10.1016/j.biocel.2004.05.009] [PMID: 15325588]

Bincoletto, C.; Bechara, A.; Pereira, G.J.S.; Santos, C.P.; Antunes, F.; Peixoto da-Silva, J.; Muler, M.; Gigli, R.D.; Monteforte, P.T.; Hirata, H.; Jurkiewicz, A.; Smaili, S.S. Interplay between apoptosis and autophagy, a challenging puzzle: New perspectives on antitumor chemotherapies. Chem. Biol. Interact., 2013, 206(2), 279-288.
[http://dx.doi.org/10.1016/j.cbi.2013.09.018] [PMID: 24121004]

An, J.; Zhou, Q.; Wu, M.; Wang, L.; Zhong, Y.; Feng, J.; Shang, Y.; Chen, Y. Interactions between oxidative stress, autophagy and apoptosis in A549 cells treated with aged black carbon. Toxicol. In Vitro, 2019, 54, 67-74.
[http://dx.doi.org/10.1016/j.tiv.2018.09.008] [PMID: 30240709]

Bauvy, C.; Gane, P.; Arico, S.; Codogno, P.; Ogier-Denis, E. Autophagy delays sulindac sulfide-induced apoptosis in the human intestinal colon cancer cell line HT-29. Exp. Cell Res., 2001, 268(2), 139-149.
[http://dx.doi.org/10.1006/excr.2001.5285] [PMID: 11478840]

Lockshin, R.A.; Zakeri, Z. Apoptosis, autophagy, and more. Int. J. Biochem. Cell Biol., 2004, 36(12), 2405-2419.
[http://dx.doi.org/10.1016/j.biocel.2004.04.011] [PMID: 15325581]

Esteve, J.M.; Knecht, E. Mechanisms of autophagy and apoptosis: Recent developments in breast cancer cells. World J. Biol. Chem., 2011, 2(10), 232-238.
[http://dx.doi.org/10.4331/wjbc.v2.i10.232] [PMID: 22031846]

Sivridis, E.; Koukourakis, M.I.; Zois, C.E.; Ledaki, I.; Ferguson, D.J.P.; Harris, A.L.; Gatter, K.C.; Giatromanolaki, A. LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. Am. J. Pathol., 2010, 176(5), 2477-2489.
[http://dx.doi.org/10.2353/ajpath.2010.090049] [PMID: 20382705]

Yang, Y.; Hu, L.; Zheng, H.; Mao, C.; Hu, W.; Xiong, K.; Wang, F.; Liu, C. Application and interpretation of current autophagy inhibitors and activators. Acta Pharmacol. Sin., 2013, 34(5), 625-635.
[http://dx.doi.org/10.1038/aps.2013.5] [PMID: 23524572]

Amaravadi, R.K.; Lippincott-Schwartz, J.; Yin, X.M.; Weiss, W.A.; Takebe, N.; Timmer, W.; DiPaola, R.S.; Lotze, M.T.; White, E. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res., 2011, 17(4), 654-666.
[http://dx.doi.org/10.1158/1078-0432.CCR-10-2634] [PMID: 21325294]

Shacka, J.J.; Klocke, B.J.; Roth, K.A. Autophagy, bafilomycin and cell death: the “a-B-cs” of plecomacrolide-induced neuroprotection. Autophagy, 2006, 2(3), 228-230.
[http://dx.doi.org/10.4161/auto.2703] [PMID: 16874105]

Yang, Z.J.; Chee, C.E.; Huang, S.; Sinicrope, F.A. The role of autophagy in cancer: Therapeutic implications. Mol. Cancer Ther., 2011, 10(9), 1533-1541.
[http://dx.doi.org/10.1158/1535-7163.MCT-11-0047] [PMID: 21878654]

Wang, C.; Hu, Q.; Shen, H.M. Pharmacological inhibitors of autophagy as novel cancer therapeutic agents. Pharmacol. Res., 2016, 105, 164-175.
[http://dx.doi.org/10.1016/j.phrs.2016.01.028] [PMID: 26826398]

Kinsey, C.G.; Camolotto, S.A.; Boespflug, A.M.; Guillen, K.P.; Foth, M.; Truong, A.; Schuman, S.S.; Shea, J.E.; Seipp, M.T.; Yap, J.T.; Burrell, L.D.; Lum, D.H.; Whisenant, J.R.; Gilcrease, G.W., III; Cavalieri, C.C.; Rehbein, K.M.; Cutler, S.L.; Affolter, K.E.; Welm, A.L.; Welm, B.E.; Scaife, C.L.; Snyder, E.L.; McMahon, M. Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat. Med., 2019, 25(4), 620-627.
[http://dx.doi.org/10.1038/s41591-019-0367-9] [PMID: 30833748]

Levy, J.M.M.; Thompson, J.C.; Griesinger, A.M.; Amani, V.; Donson, A.M.; Birks, D.K.; Morgan, M.J.; Mirsky, D.M.; Handler, M.H.; Foreman, N.K.; Thorburn, A. Autophagy inhibition improves chemosensitivity in BRAFV600E brain tumors. Cancer Discov., 2014, 4(7), 773-780.
[http://dx.doi.org/10.1158/2159-8290.CD-14-0049] [PMID: 24823863]

Mulcahy Levy, J.M.; Zahedi, S.; Griesinger, A.M.; Morin, A.; Davies, K.D.; Aisner, D.L.; Kleinschmidt-DeMasters, B.K.; Fitzwalter, B.E.; Goodall, M.L.; Thorburn, J.; Amani, V.; Donson, A.M.; Birks, D.K.; Mirsky, D.M.; Hankinson, T.C.; Handler, M.H.; Green, A.L.; Vibhakar, R.; Foreman, N.K.; Thorburn, A. Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumors. eLife, 2017, 6, e19671.
[http://dx.doi.org/10.7554/eLife.19671] [PMID: 28094001]

Levy, J.M.M.; Towers, C.G.; Thorburn, A. Targeting autophagy in cancer. Nat. Rev. Cancer, 2017, 17(9), 528-542.
[http://dx.doi.org/10.1038/nrc.2017.53] [PMID: 28751651]

Hale, A.; Ledbetter, D.; Gawriluk, T.; Rucker, E.B., III Altering autophagy: mouse models of human disease; Autophagy-A Double-Edged Sword-Cell Survival or Death, 2013, pp. 121-138.

Zhou, Y.; Rucker, E.B., III; Zhou, B.P. Autophagy regulation in the development and treatment of breast cancer. Acta Biochim. Biophys. Sin., 2016, 48(1), 60-74.
[http://dx.doi.org/10.1093/abbs/gmv119] [PMID: 26637829]

Chen, X.; Yu, X.; Chen, J.; Yang, Z.; Shao, Z.; Zhang, Z.; Guo, X.; Feng, Y. Radiotherapy can improve the disease-free survival rate in triple-negative breast cancer patients with T1-T2 disease and one to three positive lymph nodes after mastectomy. Oncologist, 2013, 18(2), 141-147.
[http://dx.doi.org/10.1634/theoncologist.2012-0233] [PMID: 23335622]

Perou, C.M. Molecular stratification of triple-negative breast cancers. Oncologist, 2011, 16(S1)(Suppl. 1), 61-70.
[http://dx.doi.org/10.1634/theoncologist.2011-S1-61] [PMID: 21278442]

Thomas, S.; Sharma, N.; Golden, E.B.; Cho, H.; Agarwal, P.; Gaffney, K.J.; Petasis, N.A.; Chen, T.C.; Hofman, F.M.; Louie, S.G.; Schönthal, A.H. Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors. Cancer Lett., 2012, 325(1), 63-71.
[http://dx.doi.org/10.1016/j.canlet.2012.05.030] [PMID: 22664238]

Milani, M.; Rzymski, T.; Mellor, H.R.; Pike, L.; Bottini, A.; Generali, D.; Harris, A.L. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res., 2009, 69(10), 4415-4423.
[http://dx.doi.org/10.1158/0008-5472.CAN-08-2839] [PMID: 19417138]

Rao, R.; Balusu, R.; Fiskus, W.; Mudunuru, U.; Venkannagari, S.; Chauhan, L.; Smith, J.E.; Hembruff, S.L.; Ha, K.; Atadja, P.; Bhalla, K.N. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Mol. Cancer Ther., 2012, 11(4), 973-983.
[http://dx.doi.org/10.1158/1535-7163.MCT-11-0979] [PMID: 22367781]

Bianchini, G.; Balko, J.M.; Mayer, I.A.; Sanders, M.E.; Gianni, L. Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease. Nat. Rev. Clin. Oncol., 2016, 13(11), 674-690.
[http://dx.doi.org/10.1038/nrclinonc.2016.66] [PMID: 27184417]

Xu, S.W.; Law, B.Y.K.; Qu, S.L.Q.; Hamdoun, S.; Chen, J.; Zhang, W.; Guo, J.R.; Wu, A.G.; Mok, S.W.F.; Zhang, D.W.; Xia, C.; Sugimoto, Y.; Efferth, T.; Liu, L.; Wong, V.K.W. SERCA and P-glycoprotein inhibition and ATP depletion are necessary for celastrol-induced autophagic cell death and collateral sensitivity in multidrug-resistant tumor cells. Pharmacol. Res., 2020, 153, 104660.
[http://dx.doi.org/10.1016/j.phrs.2020.104660] [PMID: 31982489]

Dikic, I.; Elazar, Z. Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell Biol., 2018, 19(6), 349-364.
[http://dx.doi.org/10.1038/s41580-018-0003-4] [PMID: 29618831]

Towers, C.G.; Thorburn, A. Therapeutic targeting of autophagy. EBioMedicine, 2016, 14, 15-23.
[http://dx.doi.org/10.1016/j.ebiom.2016.10.034] [PMID: 28029600]

Mukhopadhyay, S.; Sinha, N.; Das, D.N.; Panda, P.K.; Naik, P.P.; Bhutia, S.K. Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects. Crit. Rev. Clin. Lab. Sci., 2016, 53(4), 228-252.
[http://dx.doi.org/10.3109/10408363.2015.1135103] [PMID: 26743568]

Wong, VK; Li, T; Law, BY; Ma, ED; Yip, N; Michelangeli, F Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells. Cell death & disease, 2013, 4(7), e720-e.
[http://dx.doi.org/10.1038/cddis.2013.217]

Laane, E.; Tamm, K.P.; Buentke, E.; Ito, K.; Khahariza, P.; Oscarsson, J.; Corcoran, M.; Björklund, A-C.; Hultenby, K.; Lundin, J.; Heyman, M.; Söderhäll, S.; Mazur, J.; Porwit, A.; Pandolfi, P.P.; Zhivotovsky, B.; Panaretakis, T.; Grandér, D. Cell death induced by dexamethasone in lymphoid leukemia is mediated through initiation of autophagy. Cell Death Differ., 2009, 16(7), 1018-1029.
[http://dx.doi.org/10.1038/cdd.2009.46] [PMID: 19390558]

Ouyang, L.; Zhang, L.; Fu, L.; Liu, B. A small-molecule activator induces ULK1-modulating autophagy-associated cell death in triple negative breast cancer. Autophagy, 2017, 13(4), 777-778.
[http://dx.doi.org/10.1080/15548627.2017.1283470] [PMID: 28165887]

Negri, T.; Tarantino, E.; Orsenigo, M.; Reid, J.F.; Gariboldi, M.; Zambetti, M.; Pierotti, M.A.; Pilotti, S. Chromosome band 17q21 in breast cancer: Significant association between beclin 1 loss and HER2/NEU amplification. Genes Chromosomes Cancer, 2010, 49(10), 901-909.
[http://dx.doi.org/10.1002/gcc.20798] [PMID: 20589936]

Qu, X.; Yu, J.; Bhagat, G.; Furuya, N.; Hibshoosh, H.; Troxel, A.; Rosen, J.; Eskelinen, E.L.; Mizushima, N.; Ohsumi, Y.; Cattoretti, G.; Levine, B. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest., 2003, 112(12), 1809-1820.
[http://dx.doi.org/10.1172/JCI20039] [PMID: 14638851]

Liu, F.; Lee, J.Y.; Wei, H.; Tanabe, O.; Engel, J.D.; Morrison, S.J.; Guan, J.L. FIP200 is required for the cell-autonomous maintenance of fetal hematopoietic stem cells. Blood, 2010, 116(23), 4806-4814.
[http://dx.doi.org/10.1182/blood-2010-06-288589] [PMID: 20716775]

Wei, H.; Wei, S.; Gan, B.; Peng, X.; Zou, W.; Guan, J.L. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev., 2011, 25(14), 1510-1527.
[http://dx.doi.org/10.1101/gad.2051011] [PMID: 21764854]

Chen, W.; Bai, Y.; Patel, C.; Geng, F. Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization. Biochem. Biophys. Res. Commun., 2019, 520(2), 263-268.
[http://dx.doi.org/10.1016/j.bbrc.2019.09.133] [PMID: 31590917]

Pavel, M.; Renna, M.; Park, S.J.; Menzies, F.M.; Ricketts, T.; Füllgrabe, J.; Ashkenazi, A.; Frake, R.A.; Lombarte, A.C.; Bento, C.F.; Franze, K.; Rubinsztein, D.C. Contact inhibition controls cell survival and proliferation via YAP/TAZ-autophagy axis. Nat. Commun., 2018, 9(1), 2961.
[http://dx.doi.org/10.1038/s41467-018-05388-x] [PMID: 29317637]

Shi, Y.; Gong, W.; Lu, L.; Wang, Y.; Ren, J. Upregulation of miR-129-5p increases the sensitivity to Taxol through inhibiting HMGB1-mediated cell autophagy in breast cancer MCF-7 cells. Braz. J. Med. Biol. Res., 2019, 52(11), e8657.
[http://dx.doi.org/10.1590/1414-431x20198657] [PMID: 31664305]

Tam, S.Y.; Wu, V.W.C.; Law, H.K.W. Influence of autophagy on the efficacy of radiotherapy. Radiat. Oncol., 2017, 12(1), 57.
[http://dx.doi.org/10.1186/s13014-017-0795-y] [PMID: 28320471]

Mele, L.; del Vecchio, V.; Liccardo, D.; Prisco, C.; Schwerdtfeger, M.; Robinson, N.; Desiderio, V.; Tirino, V.; Papaccio, G.; La Noce, M. The role of autophagy in resistance to targeted therapies. Cancer Treat. Rev., 2020, 88, 102043.
[http://dx.doi.org/10.1016/j.ctrv.2020.102043] [PMID: 32505806]

Redig, A.J.; McAllister, S.S. Breast cancer as a systemic disease: A view of metastasis. J. Intern. Med., 2013, 274(2), 113-126.
[http://dx.doi.org/10.1111/joim.12084] [PMID: 23844915]

Cardoso, F.; Costa, A.; Senkus, E.; Aapro, M.; André, F.; Barrios, C.H.; Bergh, J.; Bhattacharyya, G.; Biganzoli, L.; Cardoso, M.J.; Carey, L.; Corneliussen-James, D.; Curigliano, G.; Dieras, V.; El Saghir, N.; Eniu, A.; Fallowfield, L.; Fenech, D.; Francis, P.; Gelmon, K.; Gennari, A.; Harbeck, N.; Hudis, C.; Kaufman, B.; Krop, I.; Mayer, M.; Meijer, H.; Mertz, S.; Ohno, S.; Pagani, O.; Papadopoulos, E.; Peccatori, F.; Penault-Llorca, F.; Piccart, M.J.; Pierga, J.Y.; Rugo, H.; Shockney, L.; Sledge, G.; Swain, S.; Thomssen, C.; Tutt, A.; Vorobiof, D.; Xu, B.; Norton, L.; Winer, E. 3rd ESO–ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). Breast, 2017, 31, 244-259.
[http://dx.doi.org/10.1016/j.breast.2016.10.001] [PMID: 27927580]

Chang, H.; Zou, Z. Targeting autophagy to overcome drug resistance: Further developments. J. Hematol. Oncol., 2020, 13(1), 159.
[http://dx.doi.org/10.1186/s13045-020-01000-2] [PMID: 33239065]

de Souza, A.S.C.; Gonçalves, L.B.; Lepique, A.P.; de Araujo-Souza, P.S. The role of autophagy in tumor immunology—complex mechanisms that may Be explored therapeutically. Front. Oncol., 2020, 10, 603661.
[http://dx.doi.org/10.3389/fonc.2020.603661] [PMID: 33335860]

Cirone, M.; Gilardini Montani, M.S.; Granato, M.; Garufi, A.; Faggioni, A.; D’Orazi, G. Autophagy manipulation as a strategy for efficient anticancer therapies: Possible consequences. J. Exp. Clin. Cancer Res., 2019, 38(1), 262.
[http://dx.doi.org/10.1186/s13046-019-1275-z] [PMID: 31200739]

Ladoire, S.; Enot, D.; Andre, F.; Zitvogel, L.; Kroemer, G. Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy. OncoImmunology, 2016, 5(2), e1082706.
[http://dx.doi.org/10.1080/2162402X.2015.1082706] [PMID: 27057465]

Karamouzis, M.V.; Likaki-Karatza, E.; Ravazoula, P.; Badra, F.A.; Koukouras, D.; Tzorakoleftherakis, E.; Papavassiliou, A.G.; Kalofonos, H.P. Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and molecular prognostic factors. Int. J. Cancer, 2002, 102(1), 86-90.
[http://dx.doi.org/10.1002/ijc.10654] [PMID: 12353238]

Liang, X.H.; Jackson, S.; Seaman, M.; Brown, K.; Kempkes, B.; Hibshoosh, H.; Levine, B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature, 1999, 402(6762), 672-676.
[http://dx.doi.org/10.1038/45257] [PMID: 10604474]

Lock, R.; Roy, S.; Kenific, C.M.; Su, J.S.; Salas, E.; Ronen, S.M.; Debnath, J. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell, 2011, 22(2), 165-178.
[http://dx.doi.org/10.1091/mbc.e10-06-0500] [PMID: 21119005]

van Reesema, L.L.S.; Zheleva, V.; Winston, J.S.; Jansen, R.J.; O’Connor, C.F.; Isbell, A.J.; Bian, M.; Qin, R.; Bassett, P.T.; Hinson, V.J.; Dorsch, K.A.; Kirby, B.W.; Van Sciver, R.E.; Tang-Tan, A.M.; Harden, E.A.; Chang, D.Z.; Allen, C.A.; Perry, R.R.; Hoefer, R.A.; Tang, A.H. SIAH and EGFR, two RAS pathway biomarkers, are highly prognostic in locally advanced and metastatic breast cancer. EBioMedicine, 2016, 11, 183-198.
[http://dx.doi.org/10.1016/j.ebiom.2016.08.014] [PMID: 27569656]

Gupta, G.K.; Collier, A.L.; Lee, D.; Hoefer, R.A.; Zheleva, V.; Siewertsz van Reesema, L.L.; Tang-Tan, A.M.; Guye, M.L.; Chang, D.Z.; Winston, J.S.; Samli, B.; Jansen, R.J.; Petricoin, E.F.; Goetz, M.P.; Bear, H.D.; Tang, A.H. Perspectives on triple-negative breast cancer: Current treatment strategies, unmet needs, and potential targets for future therapies. Cancers, 2020, 12(9), 2392.
[http://dx.doi.org/10.3390/cancers12092392] [PMID: 32846967]

Marsh, T; Kenific, CM; Suresh, D; Gonzalez, H; Shamir, ER; Mei, W Autophagic degradation of NBR1 restricts metastatic outgrowth during mammary tumor progression. Developmental cell, 2020, 52(5), 591-604.
[http://dx.doi.org/10.1016/j.devcel.2020.01.025]

Katsuragi, Y.; Ichimura, Y.; Komatsu, M. Regulation of the Keap1–Nrf2 pathway by p62/SQSTM1. Curr. Opin. Toxicol., 2016, 1, 54-61.
[http://dx.doi.org/10.1016/j.cotox.2016.09.005]

Jiang, X.; Bao, Y.; Liu, H.; Kou, X.; Zhang, Z.; Sun, F.; Qian, Z.; Lin, Z.; Li, X.; Liu, X.; Jiang, L.; Yang, Y. VPS34 stimulation of p62 phosphorylation for cancer progression. Oncogene, 2017, 36(50), 6850-6862.
[http://dx.doi.org/10.1038/onc.2017.295] [PMID: 28846113]

Thibault, B.; Ramos-Delgado, F.; Guillermet-Guibert, J. Targeting class I-II-III PI3Ks in cancer therapy: Recent advances in tumor biology and preclinical research. Cancers, 2023, 15(3), 784.
[http://dx.doi.org/10.3390/cancers15030784] [PMID: 36765741]